Insmed | Rentekostnader



Interest Expense On Debt Endring Dato
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Cytokinetics USD 22.59M 296K 2024-12
DBV Technologies 784.71K 632.24K 2022-06
Dynavax Technologies USD 1.7M 5K 2024-12
Gilead Sciences USD 248M 10M 2024-12
Insmed USD 19.8M 532K 2024-12
Novartis USD 275M 11M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Insmed Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.